Fundraising FoxVisusNano
3 known investors
Find your way into VisusNano
Sign up to see every warm intro you have to VisusNano
- Paths you didn't know you had: your email and LinkedIn already hold routes to the VisusNano team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
VisusNano develops ophthalmic drug delivery products, focusing on treatments for ocular and eye diseases. The company combines expertise in drug delivery, ophthalmic surgery, and clinical trials to create products for eye-care patients.
Founders & leadership
TK
Tom KempChief Technology OfficerHe has over 25 years of experience in drug delivery device development and holds a PhD in MEMS, with more than 60 patents in the field.
Board
PR
Paul RosenNon Executive Director
Investors · 3
Companies House · registry record
View on Companies House ↗- Registered name
- VISUSNANO LIMITED
- Company number
- 10116150
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 11 Apr 2016
- Registered office
- Camburgh House, 27 New Dover Road, Canterbury, Kent, CT1 3DN
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 30 Apr 2025 · next due 31 Jan 2027
- Confirmation statement
- last made up to 10 Apr 2026 · next due 24 Apr 2027
Current officers · 4
- Philip Alexander — director, appointed 11 Apr 2016
- David Ian Ford — director, appointed 1 Jun 2022
- Joanna Mary Gould — director, appointed 11 Apr 2016
- Paul Henry Rosen — director, appointed 1 Jan 2021
Source: Companies House public register · retrieved 16 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does VisusNano do?
- VisusNano develops ophthalmic drug delivery products, focusing on treatments for ocular and eye diseases. The company combines expertise in drug delivery, ophthalmic surgery, and clinical trials to create products for eye-care patients.
- Who are VisusNano's investors?
- VisusNano's investors include Innvotec Ltd., Oxford Investment Opportunity Network (OION), SOSV.